Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lower Urinary Tract Symptoms × Doxazosin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pheochromocytoma 2 Prostatic Hyperplasia 1 Paraganglioma 1 Lower Urinary Tract Symptoms 1

Interventions

bicalutamide 2 Transcutaneous Electric Nerve Stimulation 1 Tamoxifen 1 Sugars 1 Sodium Chloride 1 Pentosan Sulfuric Polyester 1 Dutasteride 1 Doxazosin 1 Diclofenac 1 Cystoscopy 1 Celecoxib 1 Catheters, Indwelling 1 Capsules 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01678313 2014-07-15

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Buddhist Tzu Chi General Hospital

Phase 2 Completed

140 enrolled 10 charts

Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡